PRENATE ADVANCE™ is a white oval oil-and water-soluble multivitamin/multimineral tablet which contains calcium carbonate and Microlron II® carbonyl iron. The tablet is imprinted with "PRENATE" on both sides.

Each tablet contains:

Elemental Iron (carbonyl iron) ................. 90 mg

Calcium (calcium carbonate) ................. 200 mg

Copper (cupric oxide) .............................. 2 mg

Zinc (zinc oxide) ..................................... 25 mg

Folic Acid ................................................ 1 mg

Vitamin A (beta carotene) .................... 2700 IU

Vitamin D3 (cholecalciferol) ................... 400 IU

Vitamin E (dl-alpha tocopheryl acetate) .... 30 IU

Vitamin C (ascorbic acid) ..................... 120 mg

Vitamin B1 (thiamine mononitrate) ............ 3 mg

Vitamin B2 (riboflavin) .......................... 3.4 mg

Vitamin B6 (pyridoxine HCl) .................. 20 mg

Vitamin B12 (cyanocobalamin) ............. 12 mcg

Niacinamide ........................................... 20 mg

Magnesium (magnesium oxide) ............. 30 mcg

Docusate Sodium ................................... 50 mg

Other Ingredients: carnauba wax, crospovidone, hydroxypropyl methylcellulose, magnesium stearate, propylene glycol, silicon dioxide, stearic acid, titanium dioxide, and vanillin.

INDICATIONS

PRENATE ADVANCE is a multivitamin/multimineral nutritional supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers. PRENATE ADVANCE can also be beneficial in improving the nutritional status of women prior to conception.

CONTRAINDICATIONS

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.

PRECAUTIONS

Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

ADVERSE REACTIONS

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

DOSAGE AND ADMINISTRATION

One tablet daily or as directed by a physician.

HOW SUPPLIED

Child-resistant unit-dose packs of 90 tablets--NDC 0024-1727-10

NOTICE: Contact with moisture may produce surface discoloration and/or erosion of the tablet.

KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.

Store between 15° and 30°C (59° and 86°F).

Rx only

Manufactured for

Sanofi-Synthelabo Inc.

New York, NY 10016

by Patheon Inc.

Mississauga, ON L5N 7K9

For inquiries call 1-800-446-6267

HPM02920-01-0600SS

172711-0662

PRODUCT PHOTO(S):

NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.

The product samples shown here have been supplied by the manufacturer and reproduced in full color by PDR as a quick-reference identification aid. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected overdosage, the drug' identity should be verified by chemical analysis.